A 32-year-old male patient with moderate hepatic impairment has been newly diagnosed with generalized tonic-clonic seizures (GTC). There is no other significant comorbidity. Discuss suitability of Lamotrigine, Sodium valproate, and Levetiracetam for managing his seizures following the guidelines provided by the National Institute for Health and Care Excellence (NICE). A 68-year-old female patient has been newly diagnosed with Parkinson’s disease. Her physician prescribed three orally disintegrating carbidopa/levodopa tablets (25/100 mg) per day. The patient reports to the pharmacist that has been experiencing tremors in the hands and slowness in movement towards until 60-90 minutes after taking the dose. Identify the problem and suggest a pharmacotherapy management option for this patient.Please answer at your own easy words. Answer should be to the point specific. I will rate you positive if you do so. Please don't use AI for answering this question.

Regarding the male patient, age 32, who has generalised tonic-clonic seizures and mild hepatic…

Answered: A 32-year-old male patient with…

Phlebotomy Essentials

6th Edition

ISBN:9781451194524

Author:Ruth McCall, Cathee M. Tankersley MT(ASCP)

Publisher:Ruth McCall, Cathee M. Tankersley MT(ASCP)

Chapter1: Phlebotomy: Past And Present And The Healthcare Setting

Section: Chapter Questions

Problem 1SRQ

See similar textbooks

Related questions

Question

A 32-year-old male patient with moderate hepatic impairment has been newly diagnosed with generalized tonic-clonic seizures (GTC). There is no other significant comorbidity. Discuss suitability of Lamotrigine, Sodium valproate, and Levetiracetam for managing his seizures following the guidelines provided by the National Institute for Health and Care Excellence (NICE).
A 68-year-old female patient has been newly diagnosed with Parkinson’s disease. Her physician prescribed three orally disintegrating carbidopa/levodopa tablets (25/100 mg) per day. The patient reports to the pharmacist that has been experiencing tremors in the hands and slowness in movement towards until 60-90 minutes after taking the dose. Identify the problem and suggest a pharmacotherapy management option for this patient.

Please answer at your own easy words. Answer should be to the point specific. I will rate you positive if you do so. Please don't use AI for answering this question.

Expert Solution